Technical Analysis – NZDUSD in a recovery mood; 50-SMA next in focus

NZDUSD saw its fortune improving in the short-term picture following the clear close above the 20-day simple moving average (SMA) on Tuesday, with the focus now being on the 0.6256 resistance.

Encouragingly, the price has gained extra impetus today to climb above the descending trendline drawn from the 0.7032 peak. The technical oscillators are also mirroring increasing buying appetite as the RSI is strengthening its positive momentum above its 50 neutral mark and the MACD is distancing itself above its red signal line.

If buyers preserve strength above the descending trendline and the 0.6256 bar, which is the 38.2% Fibonacci retracement of the latest downleg, the next obstacle could pop up around the 50-day simple moving average (SMA) and the 50% Fibonacci of 0.6317. Further up, the recovery may pick up steam towards the 0.6400 round level and the 61.8% Fibonacci, while a sustained move past the 78.6% Fibonacci of 0.6564 and the 0.6500 mark could put the downward trajectory at risk near June’s top of 0.6567.

On the downside, a quick reference for support could be the 20-day SMA and the 23.6% Fibonacci of 0.6181, where the constraining red Tenkan-sen line is also converging. If that area cannot buffer selling tendencies, all eyes will turn to the two-year low of 0.6059. Even lower, the price may test the 0.6000 psychological number ahead of the key 0.5916 floor from April- May 2020.

In brief, NZDUSD is expected to extend its recovery in the short-term if the 0.6256 resistance gives way. The next obstacle could pop up around the 50-day SMA at 0.6317.

Latest News

Technical Analysis – USDJPY pauses near 145.00 mark; bias titled to the upside

Daily Market Comment – Yen flirts with intervention level, UK budget U-turn lifts pound

Technical Analysis – Gold guards latest rebound; more obstacles ahead

Technical Analysis – EURUSD holds bullish bias in very short-term

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.